![Rekha Hemrajani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rekha Hemrajani
Directeur/Membre du Conseil chez
BIOAGE LABS, INC.
Fortune : 199 650 $ au 31/05/2026
Profil
Ms. Rekha Hemrajani is an Independent Director at LB Pharmaceuticals, Inc., an Independent Director at BioAge Labs, Inc., an Independent Non-Executive Director at MaxCyte, Inc., an Independent Non-Executive Director at ALX Oncology Holdings, Inc., a Director & Partner at Hemmo Pharma LLP and a Director & Partner at Hemmo Pharmaceuticals Pvt Ltd. She is on the Board of Directors at LB Pharmaceuticals, Inc., BioAge Labs, Inc., MaxCyte, Inc., ALX Oncology, Inc., ALX Oncology Holdings, Inc., Hemmo Pharma LLP and Hemmo Pharmaceuticals Pvt Ltd. Ms. Hemrajani was previously employed as a Chief Executive Officer & Director by Jiya Acquisition Corp., a President, Chief Executive Officer & Director by Aravive, Inc., an Independent Director by Adverum Biotechnologies, Inc., a Chief Operating & Financial Officer by Arcus Biosciences, Inc., a Chief Operating Officer by FLX Bio, Inc., a CFO, SVP-Business & Financial Operations by 3-V Biosciences, Inc., a VP & Head-Licensing, Mergers & Acquisitions by Onyx Pharmaceuticals, Inc., a Vice President-Business Development by Exelixis, Inc., a Vice President by Lehman Brothers, Inc., and a Founder by Ravinia Consulting, Inc. She received her undergraduate degree from the University of Michigan and an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MAXCYTE, INC. 0,07% | 17/06/2026 | 70 314 ( 0,07% ) | 85 080 $ | 31/05/2026 |
| 31/03/2026 | 33 000 ( 0,02% ) | 62 700 $ | 31/05/2026 | |
BIOAGE LABS, INC. 0,01% | 10/06/2026 | 3 000 ( 0,01% ) | 51 870 $ | 31/05/2026 |
Postes actifs de Rekha Hemrajani
| Sociétés | Poste | Début |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Directeur/Membre du Conseil | 01/04/2020 |
| MAXCYTE, INC. | Directeur/Membre du Conseil | 15/06/2021 |
| BIOAGE LABS, INC. | Directeur/Membre du Conseil | 19/08/2021 |
| LB PHARMACEUTICALS INC | Directeur/Membre du Conseil | 10/09/2025 |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company which develops therapies for cancers | Directeur/Membre du Conseil | 04/05/2020 |
Hemmo Pharma LLP | Directeur/Membre du Conseil | - |
Hemmo Pharmaceuticals Pvt Ltd.
 Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures peptide APIs | Directeur/Membre du Conseil | - |
Anciens postes connus de Rekha Hemrajani
| Sociétés | Poste | Fin |
|---|---|---|
| JIYA ACQUISITION CORP. | Directeur Général | 01/11/2022 |
| ADVERUM BIOTECHNOLOGIES, INC. | Directeur/Membre du Conseil | 12/05/2021 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Rekha Hemrajani
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
MaxCyte, Inc.
 MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rapt Therapeutics, Inc.
 Rapt Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oral small molecule therapies for patients | Health Technology |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
LB Pharmaceuticals, Inc.
 LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
BioAge Labs, Inc.
 BioAge Labs, Inc. BiotechnologyHealth Technology Develops therapies obesity for metabolic diseases | Health Technology |
Aravive, Inc.
 Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company which develops therapies for cancers | Health Technology |
Hemmo Pharmaceuticals Pvt Ltd.
Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures peptide APIs | Health Technology |
ALX Oncology Holdings, Inc.
 ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
Jiya Acquisition Corp.
 Jiya Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Hemmo Pharma LLP | |
Ravinia Consulting, Inc.
 Ravinia Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Ravinia Consulting, Inc. is a company located in the US. | Commercial Services |
Choisissez Zonebourse 
